# HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy

> **NCT05119582** · NA · COMPLETED · sponsor: **Joergen Serup** · enrollment: 20 (actual)

## Conditions studied

- Cutaneous Neurofibroma

## Interventions

- **DEVICE:** TOOsonix System ONE-M

## Key facts

- **NCT ID:** NCT05119582
- **Lead sponsor:** Joergen Serup
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-13
- **Primary completion:** 2024-01-17
- **Final completion:** 2024-01-17
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119582, "HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05119582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*